239 related articles for article (PubMed ID: 18479804)
1. Erythropoietin and erythropoietin receptor expression in normal and disturbed pregnancy.
Toth B; Fischl A; Scholz C; Kunze S; Friese K; Jeschke U
Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):192-200. PubMed ID: 18479804
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span.
Sanchez PE; Navarro FP; Fares RP; Nadam J; Georges B; Moulin C; Le Cavorsin M; Bonnet C; Ryvlin P; Belmeguenai A; Bodennec J; Morales A; Bezin L
J Comp Neurol; 2009 Jun; 514(4):403-14. PubMed ID: 19330822
[TBL] [Abstract][Full Text] [Related]
3. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
Hussein MR
Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
[TBL] [Abstract][Full Text] [Related]
4. [The role of KiSS-1 and matrix metalloproteinase-9 in regulation of invasion of trophoblasts].
Qiao C; Cheng DL; Zhang SL; Wang CH; Lin QD
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):839-42. PubMed ID: 15949403
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin and the erythropoietin receptor are expressed by papillary thyroid carcinoma from children and adolescents. Expression of erythropoietin receptor might be a favorable prognostic indicator.
Eccles TG; Patel A; Verma A; Nicholson D; Lukes Y; Tuttle RM; Francis GL
Ann Clin Lab Sci; 2003; 33(4):411-22. PubMed ID: 14584755
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin and erythropoietin receptor system in a large uterine myoma of a patient with myomatous erythrocytosis syndrome: possible relationship with the pathogenesis of unusual tumor size.
Pollio F; Staibano S; Mansueto G; De Rosa G; Persico F; De Falco M; Di Lieto A
Hum Pathol; 2005 Jan; 36(1):120-7. PubMed ID: 15712191
[TBL] [Abstract][Full Text] [Related]
7. Leptin and peroxisome proliferator-activated receptors: impact on normal and disturbed first trimester human pregnancy.
Toth B; Bastug M; Scholz C; Arck P; Schulze S; Kunze S; Friese K; Jeschke U
Histol Histopathol; 2008 Dec; 23(12):1465-75. PubMed ID: 18830932
[TBL] [Abstract][Full Text] [Related]
8. Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies.
Kokhaei P; Abdalla AO; Hansson L; Mikaelsson E; Kubbies M; Haselbeck A; Jernberg-Wiklund H; Mellstedt H; Osterborg A
Clin Cancer Res; 2007 Jun; 13(12):3536-44. PubMed ID: 17575216
[TBL] [Abstract][Full Text] [Related]
9. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
10. Expression of the pantumour Thomsen-Friedenreich antigen in the human placenta with the diagnosis of hydatidiform mole.
Richter DU; Jeschke U; Makovitzky J; Gerber B; Briese V
Anticancer Res; 2007; 27(4A):2001-3. PubMed ID: 17649812
[TBL] [Abstract][Full Text] [Related]
11. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
12. 11beta-Hydroxysteroid dehydrogenase activity in pregnancies complicated by hydatidiform mole.
Muneyyrici-Delale O; Nacharaju VL; Sidell J; Neil G; Karacan M; Camilien L; Temkin S; Abulafia O
Am J Reprod Immunol; 2006 Jun; 55(6):415-9. PubMed ID: 16674598
[TBL] [Abstract][Full Text] [Related]
13. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
Fulop V; Mok SC; Genest DR; Szigetvari I; Cseh I; Berkowitz RS
J Reprod Med; 1998 Feb; 43(2):101-10. PubMed ID: 9513871
[TBL] [Abstract][Full Text] [Related]
14. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
15. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
Cui JQ; Shi YF; Zhou HJ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
[TBL] [Abstract][Full Text] [Related]
16. [Expression of TM4SF9 in human trophoblasts].
Gao TY; Yu YH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1080-2. PubMed ID: 18583270
[TBL] [Abstract][Full Text] [Related]
17. The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation.
Rades D; Golke H; Schild SE; Kilic E
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):152-9. PubMed ID: 17967510
[TBL] [Abstract][Full Text] [Related]
18. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
Pongcharoen S; Searle RF; Bulmer JN
Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424
[TBL] [Abstract][Full Text] [Related]
19. Diminished expression of placental isoferritin p43 component in first trimester abnormal pregnancies.
Jauniaux E; Maymon R; Greenwold N; Hustin J; Moroz C
Placenta; 2000 May; 21(4):408-11. PubMed ID: 10833377
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast.
Crescimanno C; Marzioni D; Paradinas FJ; Schrurs B; Mühlhauser J; Todros T; Newlands E; David G; Castellucci M
J Pathol; 1999 Dec; 189(4):600-8. PubMed ID: 10629564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]